StonvexLoading…
StonvexStonvexStonvexCore line items from BKU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $295.53M | $6.22M | $21.73M | $15.95M | $10.56M |
Operating Income | Not available | $81.74M | $361.75M | $97.93M | $93.90M |
Net Income | Not available | $61.88M | $268.35M | $71.85M | $68.77M |
EPS (Diluted) | $1.04 | $0.83 | $3.53 | $0.95 | $0.91 |
Total Assets | Not available | $35.36B | $35.04B | $35.08B | $35.46B |
Total Liabilities | Not available | $32.34B | $31.99B | $32.04B | $32.51B |
Cash & Equivalents | Not available | $384.94M | $217.78M | $559.50M | $801.29M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 73.35M | 74.14M | 75.24M | 75.22M |